Table 3. Effect of CD-3 on TSA and LASA levels.
Group | Parameters | |||
---|---|---|---|---|
TSA levels | LASA levels | |||
Serum (µg/ml) | Liver tissue (µg/ml) | Serum (µg/ml) | Liver tissue (µg/ml) | |
Group 1 | 1.91 ± 0.075 | 0.563 ± 0.038 | 0.599 ± 0.017 | 0.175 ± 0.003 |
Group 2 | 5.71 ± 0.19* | 1.19 ± 0.042* | 1.77 ± 0.065* | 0.711 ± 0.018* |
Group 3 | 2.67 ± 0.10* | 0.793 ± 0.031* | 0.966 ± 0.028* | 0.303 ± 0.013* |
Group 1: Control; Group 2: NDEA/CCl4; Group 3: NDEA/CCl4/CD-3. Data represent the means ± SEM in each group. * P < 0.001 versus vehicle treated and NDEA/CCl4 or NDEA/CCl4/CD-3. Comparisons were made between Group 1 and Group 2 mice and between Group 2 and Group 3 mice.